Long-term impact of telemedicine for lipid control after an acute coronary syndrome
Authors' conclusion
A telemedicine-based intensive lipid-lowering strategy effectively optimized LDL-c levels and was associated with reduced cardiovascular mortality in a high-risk secondary prevention cohort.
Study context
- Population
- Patients with acute coronary syndrome (ACS)
- Participants
- 344 patients
- Outcome
- LDL-c control (LDL-c <55 mg/dL) with a telemedicine-based strategy
Methodological detailsconsecutive enrolment, single-group
- Consecutive enrolment
- Single-group
Main finding
As reported in the abstract
LDL-c control
Baseline LDL-c (mg/dL)
108.4±40.7
Post-intervention LDL-c (mg/dL)
48.7 ± 14.4
LDL-c <55 mg/dL achieved
82.6%
Average treatment optimization time (months)
3.2±2.1
Observational data: associations, not effects.
Further findings
Death and 4P-MACE · median follow-up 39±10 months
- Died
- 43 (12.5%)
- 4P-MACE event
- 72 (20.9%)
Predictors of CV mortality (multivariate analysis)
- LDL-c at end of follow-up, HR (95% CI 1.01-1.08), p0.024
- 1.04
- Age, HR (95% CI 1.02-1.16), p0.004
- 1.09
- Independently associated
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Long-term impact of telemedicine for lipid control after an acute coronary syndrome. Eur J Prev Cardiol. Published 4 October 2025. doi:10. 1093/ eurjpc/ zwaf630
Composed by AI from the published abstract and checked against it. How Briefs are made →